Optimisation of control strategies and treatment
Abstract number: 1732_30
Rates of infections caused by CA-MRSA continue to increase, causing over 50% of skin and soft tissue infections seen in the emergency department in a recent report. Strategies for control of CA-MRSA in patients and their families include use of infection control techniques in the household as well as decolonisation with mupirocin, chlorhexidine, and antibiotics in some cases. Given that CA-MRSA has been now been implicated in healthcare-associated infections, efforts to reduce the spread of this organism within the healthcare environment are also important and include appropriate hand-hygiene, isolation, and environmental decontamination. Incision and debridement remains critical in the management of most CA-MRSA infections. The use of antibiotics is indicated in many CA-MRSA infections and therapeutic options include older agents, such as clindamycin, trimethoprim-sulfamethoxazole, tetracyclines, and rifampin, and newer agents such as linezolid. In addition, new agents are in development.
|Session name:||European Society of Clinical Microbiology and Infectious Diseases|
|Location:||ICC, Munich, Germany|
|Back to top|